Serum Homocysteine Levels in Indian Children on Valproate Monotherapy

Authors

  • Shikha Swaroop Assistant Professor, Manipal Tata Medical College, Jamshedpur, India
  • Medha Mittal Associate Professor, Department of Paediatrics, Chacha Nehru Bal Chikitsalaya, Delhi, India
  • Smita Nair Assistant Professor, SMS and R, Sharda Hospital, Delhi, India
  • Reetika Saini Research Officer, Central Ayurveda Research Institute, Punjabi Bagh, New Delhi, India
  • Jyoti Bagla Professor and HOD, Department of Paediatrics, ESI Postgraduate Institute of Medical Education and Research, Basaidarapur, Delhi, India

DOI:

https://doi.org/10.3126/jnps.v42i3.45540

Keywords:

Folic acid, Homocysteine, Vitamin B12, sodium valproate

Abstract

Introduction: Various research works have reported elevated serum homocysteine levels with the use of antiepileptic drugs. This may lead to an increased risk of atherosclerosis, a higher seizure frequency and may also cause cognitive decline.

Methods: Twenty five children (Two to 12 years) on valproate monotherapy for more than one year and the same number of age and sex-matched healthy controls were enrolled. Venous blood samples were analyzed for serum homocysteine, vitamin B12 and folic acid levels. All biochemical parameters were compared between the groups.

Results: The antiepileptic drug users had significantly lower serum homocysteine levels and higher B12 levels as compared to the controls. But serum folate levels were similar between the groups. No correlation of serum homocysteine levels was observed with either serum folate, B12 or valproate.

Conclusions: The use of valproate monotherapy for epilepsy in the Indian paediatric population does not increase the risk of hyperhomocysteinemia.

Downloads

Download data is not yet available.
Abstract
82
PDF
80

Downloads

Published

2022-12-31

How to Cite

Swaroop, S., Mittal, M., Nair, S., Saini, R., & Bagla, J. (2022). Serum Homocysteine Levels in Indian Children on Valproate Monotherapy. Journal of Nepal Paediatric Society, 42(3), 50–55. https://doi.org/10.3126/jnps.v42i3.45540

Issue

Vol. 42 No. 3 (2022)

Section

Original Articles

License

Copyright (c) 2022 Shikha Swaroop, Medha Mittal, Smita Nair, Reetika Saini, Jyoti Bagla

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).